TrademarkDir
OPIS
LIVE

Serial Number

79188687

Owner

OPIS S.r.l.

Attorney

Anna Kurian Shaw

Filing Date

Feb 22, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OPIS Trademark

Serial Number: 79188687 • Registration: 5488596

OPIS is a trademark filed by OPIS S.r.l. on February 22, 2016. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

OPIS S.r.l.

Palazza Aliprandi,

Entity Type: 16

Trademark Details

Filing Date

February 22, 2016

Registration Date

June 12, 2018

Published for Opposition

March 27, 2018

Goods & Services

Business consulting in the fields of clinical research and health research; Regulatory submission management for the pharmaceutical and biotechnology industries, namely, assisting others in preparing and filing applications for clinical trial approval, pharmaceutical and health product approval

Research and development in the medical, pharmaceutical and biotechnological fields, namely, Pharmaceutical research and development, Research and development in the pharmaceutical and biotechnology fields; [ Pharmaceutical products development; ] Conducting and monitoring clinical trials for pharmaceutical products, namely, conducting clinical trials for others, monitoring pharmaceutical clinical trials for others for quality control purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a searchable database in the fields of medical, pharmaceutical and biotechnological research; Database development services for others to process data collected from clinical trials; Pharmacovigilance, namely, monitoring pharmaceutical clinical trials for others for quality control purposes, conducting quality evaluation and analysis, quality assurance, and quality control testing for others in the pharmaceutical field; Toxicology services; Contract research organization services for pharmaceutical development and clinical development and trial, namely, conducting clinical trials for others; designing and developing software for others for use in managing data in the medical, pharmaceutical and biotechnological industries

Filing History

INTERNATIONAL REGISTRATION RENEWED
Mar 5, 2026 RNWL
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 24, 2026 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 2, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 2, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Jan 2, 2025 71AG
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Jan 2, 2025 PRAN
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 30, 2024 APRE
TEAS SECTION 71 RECEIVED
Jun 4, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 12, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2023 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 13, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 13, 2023 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 13, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 13, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 13, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 9, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 9, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 9, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 9, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 9, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 9, 2023 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 6, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 19, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 18, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 12, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 12, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Mar 30, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 27, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 27, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 7, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 7, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 7, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 24, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 24, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 24, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 24, 2018 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 18, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 13, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 13, 2017 OPNR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Sep 5, 2017 GNS1
SUBSEQUENT FINAL EMAILED
Sep 5, 2017 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Sep 5, 2017 CFRC
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 17, 2017 GNS1
SUBSEQUENT FINAL EMAILED
Aug 17, 2017 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Aug 17, 2017 CFRC
NEW REPRESENTATIVE AT IB RECEIVED
Apr 27, 2017 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 22, 2017 GNFN
FINAL REFUSAL E-MAILED
Feb 22, 2017 GNFR
FINAL REFUSAL WRITTEN
Feb 22, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 21, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 21, 2016 REAP
REFUSAL PROCESSED BY IB
Jul 29, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 13, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jul 12, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 12, 2016 MAFR
ASSIGNED TO EXAMINER
Jul 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 7, 2016 REPR

Related Trademarks